The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Guselkumab Produces Long-Lasting Pharmacodynamic Effects, Disease Improvement in PsA
Continued reductions in serum acute phase proteins and collagen degradation proteins observed in patients with psoriatic arthritis receiving guselkumab may be linked to sustained symptom improvements.
Bempedoic Acid Proves Cardiovascular Benefit Across Glycemic Spectrum in New Analysis
August 30th 2023A prespecified analysis of the CLEAR Outcomes trial assessing outcomes according to glycemic status suggests bempedoic acid provided similar relative benefits across the glycemic spectrum, but the greatest absolute benefits were observed in patients with diabetes.
Acoramidis Reduces All-Cause, Cardiovascular Mortality at 30 Months in ATTR-CM
August 27th 2023With BridgeBio Pharma Inc. expecting to complete a regulatory submission prior to the close of 2023, the 30-month results of ATTRibute-CM provide the most comprehensive overview yet of the benefit-risk profile for acoramidis in ATTR-CM.
Semaglutide for HFpEF? Breaking Down the STEP-HFpEF Trial, with Javed Butler, MD
August 27th 2023Javed Butler, MD, discusses the overall results of the STEP-HFpEF trial, how he interprets the reduction in adjudicated heart failure events, and how the community's recent experience with SGLT2 inhibitors might inform uptake strategies for semaglutide 2.4 mg.